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The ab and gd T lineages are thought to arise
from a common precursor; however, the regula-
tion of separation and development of these
lineages is not fully understood. We report
here that development of ab and gd precursors
was differentially affected by elimination of
ribosomal protein L22 (Rpl22), which is ubiqui-
tously expressed but not essential for transla-
tion.Rpl22deficiencyselectivelyarresteddevel-
opment of ab-lineage T cells at the b-selection
checkpoint by inducing their death. The death
was caused by induction of p53 expression,
because p53 deficiency blocked death and
restored development of Rpl22-deficient
thymocytes. Importantly, Rpl22 deficiency led
to selective upregulation of p53 in ab-lineage
thymocytes, at least in part by increasing
p53 synthesis. Taken together, these data indi-
cate that Rpl22 deficiency activated a p53-
dependent checkpoint that produced a remark-
ably selectiveblock inabTcell developmentbut
spared gd-lineage cells, suggesting that some
ribosomal proteins may perform cell-type-
specific or stage-specific functions.
INTRODUCTION
T cells mature in the thymus through a well-defined series
of stages that can be delineated by changes in expression
of the coreceptors CD4 and CD8. The least mature T cell
precursors enter the thymus as CD4CD8 (double-
negative or DN) thymocytes, which progress to the
CD4+CD8+ (double-positive or DP) stage before selec-
tively silencing one of these coreceptors to become
mature CD4+ or CD8+ single-positive (SP) cells. During
thymopoiesis, two major types of mature T cells aregenerated that can be distinguished by the clonotypic
subunits contained within their T cell receptor complexes
(TCR): ab T cells and gd T cells. These two lineages are
thought to derive from a common DN precursor (Petrie
et al., 1992) and to separate from one another between
the CD44+CD25+ (DN2) and CD44CD25+ (DN3) stages
of development (Ciofani et al., 2006). DN thymocytes
that productively rearrange the T cell receptor (TCR) g
and TCRd loci and express a mature gdTCR (TCRgd
heterodimer associated with CD3g3 and z) are capable
of differentiating along the gd-lineage pathway while
remaining DN (Kang et al., 1998; Passoni et al., 1997). In
contrast, cells that bear an in-frame TCRb rearrangement
express the pre-TCR (TCRb-pTa heterodimer associated
with CD3gd3 and z) and are able to differentiate along
the ab-lineage pathway to the DP stage. Precursors that
have matured to the DP stage in response to pre-TCR
signals are said to have been b-selected. b-selection
stipulates that only those DN3 thymocytes in which
V(D)J recombination produces a functional TCRb protein
will survive and differentiate; those failing to do so die by
apoptosis (Dudley et al., 1994; Hoffman et al., 1996).
Pre-TCR signals that induce traversal of the b-selection
checkpoint produce four developmental outcomes: (1)
rescue of those DN3 thymocytes from apoptosis; (2)
extensive proliferative expansion (Hoffman et al., 1996);
(3) allelic exclusion at the TCRb locus, i.e., termination of
V(D)J recombination at the remaining b allele (Aifantis
et al., 1997); and (4) differentiation to the DP stage (Kruis-
beek et al., 2000).
Although signaling through the pre-TCR and gdTCR
complexes facilitates development of ab- and gd-lineage
precursors, respectively, the precise role that these
receptors play in selection of the ab and gd lineages has
been controversial (reviewed in Hayes et al., 2003;
MacDonald and Wilson, 1998). We and others have
recently provided support for the signal strength model
of ab- versus gd-lineage commitment that posits that
strong signals direct development to the gd lineage
whereas relatively weaker signals promote commitment
to the ab lineage (Haks et al., 2005; Hayes et al., 2005).Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc. 759
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ab T Cell Development Is Blocked in Rpl22/ MiceIn particular, we showed that differential activation of the
extracellular signal-regulated kinase (ERK)-early growth
response (Egr)-inhibitor of differentiation 3 (Id3) pathway
is an important element of the TCR signals that regulate
ab- versus gd-lineage choice and development (Haks
et al., 2005). Nevertheless, the regulatory cascades that
control gd-lineage commitment and development, and
how these differ from those involved in adoption of the
ab fate, remain to be established.
Rpl22 is a component of the 60S large ribosomal
subunit and colocalizes with ribosomal RNA in the nucle-
olus and the cytoplasm (Lavergne et al., 1987; Shu-Nu
et al., 2000; Toczyski et al., 1994). Although ubiquitously
expressed and associated with the ribosome, Rpl22 is
not required for translation in vitro (Lavergne et al.,
1987). Nevertheless, it remains possible that Rpl22 may
play a cell type- or developmental stage-specific role in
protein synthesis or ribosome assembly. It has also been
suggested that Rpl22 may play a role in assembly or
function of other multisubunit ribonucleoprotein (RNP)
particles (Dobbelstein and Shenk, 1995; Le et al., 2000;
Toczyski and Steitz, 1991; Wood et al., 2001). Accord-
ingly, Rpl22 has been found to associate with both viral
RNAs and proteins in infected cells and to be a component
of the telomerase holoenzyme complex (Le et al., 2000;
Leopardi et al., 1997; Toczyski and Steitz, 1991; Wood
et al., 2001). However, to date Rpl22 has not been impli-
cated in any specific developmental pathway, mecha-
nism, or disease.
We report here that despite the ubiquitous expression
of Rpl22, Rpl22-deficient (Rpl22/) mice exhibited a
profound and remarkably selective defect in the develop-
ment of ab, but not gd, T lymphocytes. Rpl22 deficiency
arrested development of ab T cell precursors at the
b-selection checkpoint. The developmental arrest was
caused by activation of a p53-dependent checkpoint,
because p53 deficiency blocked death and rescued
thymocyte development. Importantly, the selectivity of
the blockade of ab T cell development resulted from
selective induction of p53, as indicated by the fact that
p53 amounts were not elevated in Rpl22/ gd-lineage
cells. The selective increase in p53 expression caused
by Rpl22 deficiency was not associated with detectable
increases in p53 stability, but was associated with in-
creased p53 biosynthesis. Therefore, despite the germline
disruption of the Rpl22 gene, its absence activated a p53-
dependent checkpoint only in developing ab-lineage
T cells, suggesting that despite its ubiquitous expression,
Rpl22 performs a cell-type-specific or stage-specific
function that is particularly important for executing the
b-selection differentiation program.
RESULTS
Generation of Rpl22-Deficient Mice
Mouse embryonic stem (ES) cells carrying a mutation in
the Rpl22 gene were obtained from OmniBank, a library
of gene-trapped ES cell clones identified by a corre-
sponding OmniBank Sequence Tag (Zambrowicz et al.,760 Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc.2003). Inverse genomic PCR revealed that the gene-
trapping retroviral vector had inserted into chromosome
4 between coding exons 3 and 4 of the Rpl22 gene
(Figure S1 in the Supplemental Data available online).
ES cells carrying this mutation were used to generate
mice heterozygous for the Rpl22 mutation by standard
methods (Zambrowicz et al., 2003). Interbreeding of
Rpl22 heterozygotes (Rpl22+/) gave rise to the expected
Mendelian ratios of Rpl22+/+, Rpl22+/, and Rpl22/
animals (Figure S1; data not shown). To confirm that
insertion of the gene-trap vector disrupted Rpl22 expres-
sion, mRNA and protein expression was assessed by
RT-PCR and immunoblotting. Intact Rpl22 mRNA was
not detected in tissues from Rpl22/ mice (data not
shown). As expected from the systemic disruption of
the Rpl22 gene, Rpl22 protein was absent from thymus
and spleen of Rpl22/ mice (Figure S1). Remarkably,
relative to control littermates (LM), Rpl22/ mice
exhibited no substantial difference in growth rate and
size. Likewise, comprehensive clinical diagnostic and
pathologic analysis (including tests of inflammation, be-
havior, obesity, diabetes, bone, cell proliferation, and
cardiovascular function; described in detail in Beltrandel-
rio et al., 2003) revealed few differences in Rpl22/ mice
relative to those expressing Rpl22, although there was
evidence of mild glomerulonephritis in 3 of 3 Rpl22/
mice examined.
Rpl22/ Mice Exhibit CD4 and CD8 T Cell
Lymphopenia in Peripheral Lymphoid Tissues
Hematologic analysis of Rpl22/ mice revealed a
decrease in peripheral blood leukocytes relative to LM
controls, whichwas caused by a reduction in lymphocytes
(Figure 1A). No obvious changes in other blood lineages
were observed (Figure 1A). Rpl22+/ mice did not differ
substantially from Rpl22+/+ mice for any of the evaluated
cell subsets (Figure 1A). Flow-cytometric analysis indi-
cated that the decrease in lymphocytes was, in turn, due
to a substantial decrease in both CD4+ and CD8+ T cells
(Figure 1B). The reduction in peripheral blood CD4+ and
CD8+ T cells did not appear to be caused by altered
trafficking patterns; the ab T cell content of most periph-
eral lymphoid organs analyzed was similarly reduced (Fig-
ures 1C and 1D). Interestingly, the defect in generation
of mature T cells was selective for the ab lineage, as
shown by the fact that the proportion and absolute num-
ber of gd-lineage T cells in peripheral lymphoid organs
was increased (Figures 1C and 1D). This was readily
apparent in spleen, axillary, and inguinal lymph nodes
(pooled; LN), mesenteric lymph nodes (Mes.LN), Peyer’s
Patches (PP), and peritoneal exudates (PE) (Figure 1D).
These data suggest that Rpl22 deficiency selectively
impairs the generation of ab-lineage cells, while sparing
that of gd-lineage cells.
Ablation of the Rpl22 Gene Severely Blocks ab
T Cell Development
Consistent with this hypothesis, thymic cellularity of
Rpl22/ mice was markedly reduced to about 1% of
Immunity
ab T Cell Development Is Blocked in Rpl22/ MiceFigure 1. Rpl22/ Mice Exhibit T Lymphopenia in Peripheral Blood and Lymphoid Organs
(A) Peripheral complete blood cell counts. Absolute numbers of the indicated blood cell populations were determined via automated hematologic cell
analyzers.
(B) Absolute numbers of lymphocyte subsets in peripheral blood. Numbers were calculated bymultiplying themononuclear cell count (lymphocytes +
monocytes identified by CBC) by the fraction of each indicated subset identified by FACS analysis. Student’s t test was performed comparing pooled
Rpl22+/+ and Rpl22+/ data with that from Rpl22/ mice.
(C) Splenic T cell populations. The fraction of the CD4, CD8, ab, and gd T cell subsets in spleen was determined by FACS analysis and is listed in the
appropriate quadrant of the two-color histograms. The number of animals analyzed is indicated in parentheses. Statistically significant differences
determined by Student’s t test are indicated by an asterisk.
(D) Fraction of ab- and gd-lineage T cells in peripheral lymphoid organs. The proportion of ab and gd T cell subsets was determined as above. LN,
axillary plus inguinal lymph node; Mes.LN, mesenteric lymph node; PP, peyer’s patches; PE, peritoneal exudates. n = 3 for +/+ and /mice. Gate
frequencies are listed on the histograms. Graphs represent mean ± standard deviation.control. This reduction was caused by a severe impair-
ment in development of ab-lineage precursors to the
more mature DP and SP stages (Figure 2A). In particular,
Rpl22 deficiency appeared to arrest development at the
b-selection checkpoint. Indeed, relative to Rpl22-ex-
pressing LM, the proportion of CD44CD25+ DN3 thymo-
cytes at the b-selection checkpoint was increased in
Rpl22/ mice, and there was a corresponding decrease
in the proportion that had developed beyond the b-selec-
tion checkpoint to the CD44CD25 DN4 stage (Fig-
ure 2B). In contrast to the severe impairment in develop-ment of ab-lineage T cells, development of gd-lineage
cells appeared to be relatively resistant to the effects of
Rpl22 deficiency. The proportion of gd-lineage cells was
increased and the absolute number was only moderately
reduced (Figure 2C). The effect of Rpl22 deficiency on thy-
mocyte development is reminiscent of that of pre-Ta (pTa)
deficiency. pTa deficiency abrogates pre-TCR signaling,
thereby selectively impairing development of ab-lineage
T cells by arresting their maturation at the b-selection
checkpoint (Fehling et al., 1995). Like Rpl22/ mice,
pTa-deficient (Ptrca/) mice exhibited similar decreasesImmunity 26, 759–772, June 2007 ª2007 Elsevier Inc. 761
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ab T Cell Development Is Blocked in Rpl22/ MiceFigure 2. Rpl22 Deficiency Impairs Development of ab T Lineage Cells beyond the b-Selection Checkpoint
Single-cell suspensions of explanted thymocytes of the indicated genotypes were stained with Ab reactive with CD4 and CD8 (A), CD4, CD8, CD44,
and CD25 (B), or TCRb and TCRd (C) and analyzed by FACS. Gate frequencies are listed on the histograms. The absolute number of each subset was
calculated by multiplying its fractional representation determined by FACS by the absolute cell number per thymus. The results are depicted graph-
ically and represent mean ± standard deviation of 3 mice per group. DN, CD4CD8; DP, CD4+CD8+; SP, CD4+ and CD8+; DN3, CD44CD25+; DN4,
CD44CD25.in CD4+ and CD8+ ab-lineage T cells and an increase in
gd-lineage cells. However, there were some important
differences. Thymic cellularity of Ptrca/ mice was not
reduced as severely as in Rpl22/mice; more DP thymo-
cytes were produced in Ptrca/ mice; and, whereas the
absolute number of DN3 thymocytes was decreased in
Rpl22/ mice, the number of DN3 cells was increased
in Ptrca/ mice (Figures 2A and 2B). Taken together,
these data suggest that Rpl22 deficiency impairs develop-
ment of ab-lineage cells by a different mechanism than
pTa deficiency.
The Blockade of ab T Cell Development in Rpl22/
Mice Is Cell Autonomous and Complemented
by Ectopic Expression of Rpl22
Because of the ubiquitous expression of Rpl22, it was
important to determine whether the defect in T cell
development in Rpl22/ mice was intrinsic to the
hematopoietic compartment or the surrounding stroma.
To distinguish these possibilities, we constructed bone-
marrow (BM) chimeras. We found that the profile of the
developing thymocytes reflected the source of the donor
BM. Chimeras produced with BM from Rpl22+/+ mice
exhibited normal proportions of thymic CD4 and CD8 sub-
sets, irrespective of the host genotype (Figure 3A; Fig-
ure S2). In contrast, chimeras generated with Rpl22/
BM exhibited the abnormal Rpl22/ thymic phenotype,
with a striking reduction in DP thymocytes and increased
representation of DN thymocytes, many of which are of762 Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc.the gd lineage (Figures 2 and 3A). Because the defect in
thymocyte development was cell autonomous, we sought
to determine whether it could be complemented by
ectopic expression of Rpl22. To do so, fetal liver hemato-
poietic precursors from Rpl22+/+, Rpl22+/, and Rpl22/
mice were cultured on monolayers of OP9-DL1 cells,
which support development of T cells in vitro from hema-
topoietic precursors (Schmitt and Zuniga-Pflucker, 2002).
Precursors from Rpl22/mice that were infected with an
empty IRES-GFP retrovirus (pMiG) were impaired in their
ability to develop from the DN to the DP stage (Figure 3B;
left panels of d8 and d16 columns). Importantly, the ability
of Rpl22/ precursors to develop to the DP stage was
dramatically improved upon retroviral transduction with
an Rpl22 cDNA (pMiG-Rpl22) (Figure 3B; right panels of
d8 and d16 columns). Retroviral transduction with pMiG-
Rpl22 did not completely restore development of DP thy-
mocytes to the extent observed in control LM, perhaps
because the amount of Rpl22 protein expressed by
pMiG-Rpl22-transduced Rpl22/ precursors was not re-
stored to that expressed by control LM (Figure 3C). Taken
together, these data demonstrate that the defect in thy-
mocyte development in Rpl22/mice is cell autonomous
and results from the lack of Rpl22 protein expression.
Failure of Rpl22/ Thymocytes to Differentiate to
the DN4 Stage Is Selective for Cells of the ab Lineage
Because T cell development in Rpl22/ mice was
blocked at the b-selection checkpoint at DN3, we asked
Immunity
ab T Cell Development Is Blocked in Rpl22/ MiceFigure 3. The Arrest of ab T Cell Development in Rpl22/ Mice Is Cell Autonomous and Caused by the Absence of Rpl22
(A) The defect in thymocyte development inRpl22/micemaps to the hematopoietic compartment. Single-cell suspensions from the indicated bone-
marrow chimeras were analyzed by FACS as in Figure 2. Student’s t test was performed comparing pooled data from Rpl22+/+ (9 mice) donors with
data from Rpl22/ donors (13 mice). Gate frequencies are listed on the histograms in (A) and (B). Histograms are representative of 2 experiments.
(B) Ectopic expression of Rpl22 complements the defect in Rpl22/ thymocyte development. Fetal liver precursors from day 13.5 of gestation were
transduced with empty pMiG or pMiG-Rpl22 on day 4 of culture. Developmental progression was monitored by flow cytometry on days 8 and 16 of
culture by electronically gating on GFP+ cells. Histograms are representative of 2 experiments.
(C) Retroviral transduction with pMiG-Rpl22 partially restores Rpl22 protein expression. GFP+ cells from the cultures in (B) were isolated by flow
cytometry on day 16 of culture. Cell extracts were blotted with anti-Rpl22 and visualized by chemiluminescence.whether this resulted from the inability to produce TCRb
protein and initiate pre-TCR signaling. Accordingly, we
performed intracellular staining to detect expression of
the TCRb protein. In Rpl22-expressing DN3 (CD25+)
thymocytes, the fraction of cells that expressed TCRb
protein was between 15% and 20%, consistent with pre-
vious analysis (Figure 4A; Wilson et al., 1999). The fraction
of TCRb-expressing cells was increased further to 55%–
60% among Rpl22-expressing (CD25) DN4 thymocytes,
as is expected for cells that have traversed the b-selection
checkpoint (Figure 4A; Dudley et al., 1994; Hoffman et al.,
1996; Wilson et al., 1999). Interestingly, in Rpl22/ mice,the fraction of TCRb-expressing DN3 thymocytes was
actually higher (55%); however, very few of those
TCRb-expressing cells downregulated CD25 and differen-
tiated to the DN4 stage, suggesting that there was selec-
tion against differentiation of TCRb-expressing cells in
Rpl22/mice (Figure 4A). Consistent with this possibility,
most of the DN4 thymocytes in Rpl22/ mice lacked
TCRb expression, but many did express the gdTCR
complex, showing that the gdTCR complex was capable
of promoting development to the DN4 stage (Figure 4B).
The failure of most Rpl22/ DN3 thymocytes to mature
to the DN4 stage did not appear to result from the absenceImmunity 26, 759–772, June 2007 ª2007 Elsevier Inc. 763
Immunity
ab T Cell Development Is Blocked in Rpl22/ MiceFigure 4. Impaired Development of ab-Lineage Thymocytes Is Associated with Excessive Apoptosis
Single-cell suspensions of thymocytes from mice with the indicated genotypes were analyzed by FACS as above.
(A) Fraction of TCRb-expressing DN3 and DN4 thymocytes. Thymocytes stained with Ab reactive with CD4, CD8, CD44, and CD25 were fixed,
permeabilized, and then subjected to intracellular staining with anti-TCRb. Gate frequencies are listed on the histograms in (A)–(E).
(B) Fraction of TCRgd-expressing DN3 and DN4 thymocytes. Thymocytes were stained for CD4, CD8, CD44, CD25, and TCRd. The histograms
represent electronically gated DN further gated for the absence of CD44 expression (i.e., DN3 and DN4 subsets; [A] and [B]).
(C) Thymocytes were stained as in (B) with the indicated Ab.
(D and E) Single-cell suspensions were subjected to FACS analysis as above. Histograms represent thymocytes gated (D) for FSC and SSC or (E) for
Annexin V to identify apoptotic cells. The proportion of viable (D) and apoptotic (E) cells is depicted graphically and represents mean ± standard
deviation of three mice per group.
(F and G) Apoptosis is elevated among ab-lineage precursors. Thymocyte suspensions were stained with Ab reactive to CD4, CD8, TCRb, TCRb, and
with Annexin V. The change in apoptosis in Rpl22/ thymocytes was normalized to the equivalent subset from LM controls and plotted in histogram
form (F). Data represent normalized mean ± standard deviation and are representative of three experiments performed.
(G) Apoptosis among gd-lineage precursors (defined by expression of the gdTCR) and ab-lineage precursors (defined by absence of the gdTCR) was
determined as in (F).
(H) Anti-CD3 stimulation induces apoptosis of ab-lineage T cells from Rpl22/mice. Splenic T cells were stimulated for 20 hr with plate-bound anti-
CD3, after which apoptosis was determined by flow cytometry with Annexin V staining. Results are depicted graphically as in (G).of signaling, because about 30% of Rpl22/ DN3
exhibited increased expression of the CD5 activation
marker (Figure 4C; right) indicating that they have received
a signal. These data suggest that the developmental arrest
in Rpl22/ mice was not caused by a defect in pre-TCR764 Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc.expression or function, because most Rpl22/ DN3
expressed TCRb protein and appeared to have received
a TCR signal. Moreover, the enrichment of gdTCR-
expressing cells and depletion of TCRb-expressing cells
among the DN4 subpopulation demonstrates that the
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ab T Cell Development Is Blocked in Rpl22/ Miceimpaired development of DN3 thymocytes to the DN4
stage caused by Rpl22 deficiency was selective for cells
of the ab lineage. Interestingly, despite the fact that B
cell progenitors undergo a similar transition in response
to signals by the pre-B cell receptor, neither that transition
nor B cell development in general was substantially
altered in Rpl22/ mice (Figure S3; Melchers, 2005).
Elevated Apoptosis in Rpl22/ Mice Is Restricted
to ab-Lineage Cells
We reasoned that ab-lineage precursors might fail to
develop in Rpl22/ mice because they undergo apopto-
sis. Consistent with this hypothesis, flow-cytometry
analysis revealed that significantly fewer Rpl22/ thymo-
cytes fall in the FSC-SSC live cell gate and there was
a commensurate increase in those that stain positive for
the apoptoticmarker Annexin V (Figures 4D and 4E; Fadok
et al., 1992). Like the defect in thymocyte development,
the excessive apoptosis observed in Rpl22/ thymo-
cytes was cell autonomous (Figures S2 and S4) and com-
plemented by ectopic expression of Rpl22 (Figure S5).
Quantification of annexin staining on electronically gated
thymocyte subsets revealed that the DP and CD4+
subpopulations exhibited the greatest increase in apopto-
sis inRpl22/mice (Figure 4F). Curiously, DN thymocytes
did not exhibit an increase in apoptosis (Figure 4F), per-
haps because apoptotic cells among this subset may be
rapidly eliminated by phagocytosis (Schlegel et al.,
2000). Importantly, in contrast to ab-lineage thymocytes,
Rpl22/ gd-lineage thymocytes (i.e., gdTCR-expressing
cells) did not exhibit an increase in apoptosis (Figure 4G).
Differential susceptibility of Rpl22/ ab- and gd-lineage
cells to apoptosis was also manifested upon anti-CD3
stimulation of peripheral T cells (Figure 4H). The basis
for differential sensitivity is unclear but did not appear to
result from the inability to transduce signals, because
abTCR-expressing cells from Rpl22/ mice exhibited
normal induction of activation markers CD25 and CD69
(Figure S6).
To investigate whether the differential sensitivity of ab-
lineage precursors to Rpl22 deficiency was associated
with differences in Rpl22 expression, we examined Rpl22
protein expression by immunoblotting. As has been re-
ported for other ribosomal structural proteins, anti-CD3
stimulation of mature T cells increased the expression of
Rpl22 (Figure 5A; Asmal et al., 2003). Moreover, this was
also true for Rag2/ thymocytes stimulated in vivo with
anti-CD3, a stimulus that mimics pre-TCR signaling (Fig-
ure 5B; Shinkai and Alt, 1994). The increase in Rpl22 pro-
tein was not accompanied by increased mRNA (data not
shown). Rpl22 protein abundance also increased as DN3
thymocytes traversed the b-selection checkpoint to the
DN4 stage (Figure 5C). Importantly, expression of Rpl22
in DN4 thymocytes was greater than in gd-lineage cells
(Figure 5C). The increased expression of Rpl22 occurs
during the developmental transition that is blocked by
Rpl22 deficiency, suggesting that increased Rpl22 ex-
pression is important for ab-lineage precursors to differ-
entiate in response to pre-TCR signaling.Selective Induction of p53 Is Responsible
for Impairing Development of Rpl22/
ab-Lineage T Cells
Because a recent report demonstrated that conditional
ablation of the Rps6 gene in immature thymocytes com-
pletely blocked thymocyte development through activa-
tion of a p53-dependent checkpoint, we considered that
Rpl22 deficiency might be acting through a similar mech-
anism (Sulic et al., 2005). In fact, p53 protein expression
was found to be higher in thymocytes from Rpl22/
mice than in Rpl22+/+ LM (Figure 5D). Interestingly, how-
ever, p53 expression was not elevated in untreated
Rpl22/ mouse embryonic fibroblasts (MEF), but could
be induced upon UV irradiation (Figure 5D). This indicates
that Rpl22 deficiency induces p53 in some cell types but
not others, providing a potential explanation for selective
blockade of ab T cell development in Rpl22/ mice. To
determine whether p53 induction were responsible for
the developmental arrest in Rpl22/ mice, we asked
whether knocking down p53 expression by shRNA would
rescue development of Rpl22/ fetal liver precursors on
OP9-DL1 monolayers (Dickins et al., 2005). The ability of
the p53shRNA to knock down p53 expression was verified
in the thymic lymphoma cell line, Scid.adh (Figure 5D). In-
deed, knocking down p53 expression (LMP-p53shRNA)
restored development of Rpl22/ cells to the DP stage
to a slightly greater extent than did transduction of
Rpl22 (Figure 5E). To determine whether the incomplete
rescue exhibited by the LMP-p53shRNA resulted from in-
complete knockdown of p53 expression, the Rpl22/
mice were crossed with p53-deficient mice to totally
eliminate p53. Importantly, the blockade of ab-lineage
development was completely rescued by p53 deficiency
(Figure 5F). p53 deficiency suppressed cell death and
completely restored both thymic cellularity and develop-
ment of ab-lineage cells to the DP and SP stages
(Figure 5F). Therefore, the developmental arrest of ab-
lineage precursors by the Rpl22 mutation results from
activation of a p53-dependent checkpoint. Moreover,
p53 induction occurs selectively in ab-lineage DN3 cells
(Figure 5G), providing an explanation for why Rpl22 defi-
ciency arrests development of ab-lineage T cells, while
sparing that of gd-lineage cells.
Rpl22 Deficiency Increases p53 Synthesis
To investigate the basis for p53 induction in Rpl22/
thymocytes, we employed mice that were double-defi-
cient for Rag2 and Rpl22. By stimulating thymocytes
from these mice (and LM control) with anti-CD3, we are
able to synchronize the delivery of a stimulus that mimics
pre-TCR signaling and then monitor the kinetics of
development beyond the point of developmental arrest
at the DN3 stage (Shinkai and Alt, 1994). Stimulation of
Rpl22+/Rag2/ thymocytes with anti-CD3 caused upre-
gulation of CD8 and development to the DP stage by 48
and 72 hr after stimulation, respectively (Figure 6A). How-
ever, anti-CD3 stimulation of Rpl22/Rag2/ thymo-
cytes did not induce appreciable differentiation beyond
the DN stage or the increase in cellularity typicallyImmunity 26, 759–772, June 2007 ª2007 Elsevier Inc. 765
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ab T Cell Development Is Blocked in Rpl22/ MiceFigure 5. Blockade of ab T Cell Development in Rpl22-Deficient Mice Is p53 Dependent
(A–C) TCR signaling induces Rpl22 expression.
(A) Spleen T cells were stimulated with plate-bound anti-CD33 for the indicated time.
(B) Rag2/ thymocytes were stimulated with anti-CD3 for the indicated time by i.p. injection.
(C) DN3, DN4, and gdTCR-expressing thymocytes were isolated by flow cytometry. Detergent extracts were blotted with anti-Rpl22 or the anti-
calnexin loading control. Bound Ab was visualized by chemiluminescence (A–C).
(D) MEFs treated as indicated as well as thymocytes from Rpl22+/+ and Rpl22/ mice were extracted and blotted with Ab to p53, Rpl22, or b-actin,
after which bound Ab were visualized by chemiluminesence (top). Scid.adh thymic lymphoma cells were infected with either control virus (LMP) or
a p53shRNA construct (LMP-p53-shRNA), after which p53 protein expression was assessed by immunoblotting (bottom).
(E) Knockdown of p53 rescues development of Rpl22/HSC to the DP stage of thymocyte development.Rpl22+/+ and Rpl22/ fetal liver HSCwere
retrovirally transduced with vector controls (pMiG or LMP), pMiG-Rpl22, or a p53 shRNA construct (LMP-p53shRNA) and cultured on OP9-DL1766 Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc.
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ab T Cell Development Is Blocked in Rpl22/ Miceassociated with the DN to DP transition (Figure 6A). The
blockade of differentiation was associated with an
increase in p53 protein expression that was not accom-
panied by increased p53 mRNA, as expected because
the regulation of p53 expression is predominantly post-
transcriptional (Figure 6B; Brooks and Gu, 2003). To de-
termine whether p53 induction in anti-CD3-stimulated
Rpl22/ thymocytes resulted from increased synthesis
or stability, we performed metabolic labeling analysis on
Rpl22/Rag2/ and Rpl22+/+Rag2/ thymocytes 40 hr
after anti-CD3 stimulation. Rpl22/Rag2/ thymocytes
exhibited a slight decrease in overall [35S]methionine
incorporation (Figure 6C, left), but there were no obvious
differences in the spectrum of proteins synthesized, in
agreement with previous studies suggesting that Rpl22 is
not essential for translation (Figure 6C, middle; Lavergne
et al., 1987). Importantly, Rpl22/ thymocytes did exhibit
amarked increase in the amount of p53 synthesizedduring
the 30min pulse, whereas that of the CD3 components re-
mained unchanged relative to Rpl22-expressing LM
(Figure 6C). The increased synthesis of p53 was not
accompanied by increased stability during the chase, sug-
gesting that the increase in p53 expression in anti-CD3-
treated Rpl22/Rag2/ thymocytes results primarily
from increased p53 synthesis (Figure 6D).
DISCUSSION
Here we report an unexpected role for Rpl22 in ab versus
gd T lineage separation that was revealed by disrupting
the Rpl22 gene. Rpl22/ mice exhibit T lymphopenia in
peripheral blood and lymphoid organs that affects T cells
of the ab lineage, while sparing those of the gd lineage.
The T lymphopenia results from a profound, selective
blockade of the differentiation of ab-lineage precursors
beyond the b-selection checkpoint. Rpl22 deficiency
selectively blocks the development of ab-lineage T cells
by activating p53 in ab-lineage, but not gd-lineage, precur-
sors, and Rpl22 deficiency appears to do so primarily by
increasing p53 biosynthesis. Taken together, these obser-
vations suggest that Rpl22 plays an important, cell-auton-
omous role in thymocyte development by regulating the
activation of p53 in a cell-lineage-restricted manner.
Rpl22/ DN3 thymocytes that are arrested at the
b-selection checkpoint do not exhibit an increase in
apoptosis. The reason for this is unclear, but may result
from rapid clearance of apoptotic cells by thymic phago-
cytes (Schlegel et al., 2000). Nevertheless, those cells
that have traversed the b-selection checkpoint display
excessive apoptosis, as evidenced both by FSC-SSC
gating and annexin staining. The survival defect is
restricted to ab-lineage T cells, sparing those of the gdlineage. The correlation between selective blockade of
ab-lineage development and increased apoptosis has
also been noted in mice deficient for Ets1, Bcl11b, and
Dnmt1 (Eyquem et al., 2004; Lee et al., 2001; Wakabaya-
shi et al., 2003). The blockade of ab-lineage development
in Bcl11b/mice results from impaired expression of the
pre-TCR complex; however, the basis for impairment in
Ets1/ and Dnmt1/ mice has not been determined.
The impairment of ab T cell development beyond the
b-selection checkpoint in Rpl22/ mice does not appear
to result from interference with pre-TCR expression.
Rpl22/ DN3 thymocytes express TCRb protein, and
their ability to express the gdTCR on the cell surface indi-
cates that they express all the CD3 components as well.
Moreover, stimulation with anti-CD3, which mimics
pre-TCR signaling, is unable to rescue development of
Rpl22/Rag2/ thymocytes, despite inducing expres-
sion of the CD5 activation marker to the same extent as
in Rpl22-expressing LM (data not shown; Shinkai and
Alt, 1994). Taken together, these data indicate that the
impairment of development is not specific for the pre-
TCR complex per se. Rather, Rpl22 function appears to
be important for ab-lineage precursors to differentiate in
response to pre-TCR signaling, a process during which
Rpl22 expression is normally induced.
The blockade of ab T cell development inRpl22/mice
ultimately results from activation of p53, because devel-
opment is fully rescued by eliminating p53 expression.
Rescue of thymocyte development by p53 deficiency
has also been observed in other strains of knockout
mice. The p53 dependence of developmental arrest in
some of these mutant strains is not unexpected because
of the involvement of the targeted proteins in regulating
genome stability (e.g., Bloom’s Syndrome Protein, DNA-
PK, and Brca-1) or in regulating p53 activity (Wip1) (Babbe
et al., 2007; Guidos et al., 1996; Mak et al., 2000; Schito
et al., 2006). Interestingly, mutations that disrupt pre-
TCR expression (e.g., CD3g and Bcl-11b) are also
rescued by p53 deficiency to varying degrees, but usually
only modestly or after temporal delay (Haks et al., 1999;
Okazuka et al., 2005). These observations led to the
hypothesis that pre-TCR signaling acts to suppress p53
activity (Kruisbeek et al., 2000). While pre-TCR signaling
defects are not acutely and/or fully rescued by p53
deficiency, the notion that pre-TCR signaling suppresses
p53 activity is intriguing given that pre-TCR signaling
induces Rpl22 expression. The upregulation of Rpl22
expression may be one of the mechanisms by which
p53 activity is controlled by pre-TCR signals.
Rpl22 deficiency induces p53 expression in anti-CD3-
stimulated Rag2/ thymocytes primarily by increasing
its biosynthesis. There are three possibilities wherebymonolayers for the indicated times. Histograms of CD4 and CD8 expression on electronically gated GFP+ cells are depicted. Gate frequencies are
listed on the histograms in (E) and (F).
(F) p53 deficiency rescues development of Rpl22/ thymocytes. Explanted thymocytes from adult mice of the indicated genotypes were analyzed
with the indicated Ab. Two-color histograms of the resulting analysis are presented. Thymic cellularity ± standard deviation is listed above the histo-
grams. A minimum of four mice per genotype were analyzed.
(G) DN3, DN4, and gdTCR-expressing thymocyte populations were isolated by flow cytometry and blotted for p53 and calnexin as above.Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc. 767
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ab T Cell Development Is Blocked in Rpl22/ MiceFigure 6. Rpl22 Deficiency Induces p53 Expression by Increasing p53 Synthesis
(A) Rpl22 deficiency impairs differentiation of anti-CD33-stimulated Rag2/ thymocytes. Mice of the indicated genotypes were injected either with
PBS or anti-CD33, and differentiation was monitored by flow cytometry at the indicated times. Two-color histograms of the resulting analysis are
presented with gate frequencies listed on the plots. A bar graph of the number of cells per thymus at each time point is depicted below.
(B) Anti-CD3 stimulation of Rpl22/Rag2/ thymocytes increases p53 protein expression. p53 mRNA abundance was not increased by anti-CD3
stimulation. Cells stimulated as in (A) were either detergent extracted and resolved by SDS-PAGE prior to blotting (top) or lysed in guanidinium, after
which p53 mRNA was quantified relative to b-actin by real-time PCR and normalized to b-actin loading control. The results are depicted graphically
and represent mean ± standard deviation of three mice per group.
(C) Anti-CD3 stimulation of Rpl22/Rag2/ thymocytes increased p53 synthesis. Mice of the indicated genotypes were stimulated with anti-CD33
for 40 hr as above, after which explanted cells were metabolically labeled with [35S]methionine for 30 min and chased for 1 or 2 hr. Aliquots of the
detergent extracts were TCA precipitated in triplicate to assess total radioactive incorporation. The mean ± standard deviation from three experi-
ments was depicted graphically. In addition, the detergent extracts were either resolved directly by SDS-PAGE or after immunoprecipitation with768 Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc.
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ab T Cell Development Is Blocked in Rpl22/ MiceRpl22 deficiency might do so. First, Rpl22 deficiency may
induce p53 synthesis through general derepression of
global or CAP-dependent protein synthesis. Neverthe-
less, our metabolic labeling studies revealed that the
rate of protein synthesis exhibited by Rpl22/ thymo-
cytes was similar to that of control LM. Second, Rpl22
deficiency may increase p53 synthesis because Rpl22
may normally function to directly suppress p53 transla-
tion. Nucleolin and thymidylate synthase have been
shown to bind to elements in the 50 untranslated and cod-
ing regions of p53 mRNA, respectively, and repress its
translation (Chu et al., 1999; Ju et al., 1999; Takagi et al.,
2005). If Rpl22 were able to directly suppress p53 synthe-
sis, it would be the first example of a ribosomal protein
with this capability, although ribosomal protein Rpl26 has
been reported to augment p53 translation (Takagi et al.,
2005). Nevertheless, the direct repression of p53 transla-
tion by Rpl22 seems too simplistic to explain the cell-
type or stage specificity of p53 induction by Rpl22 defi-
ciency, unless the ability of Rpl22 to suppress is modified
by a cofactor whose expression or activity is cell-type or
stage restricted. Finally, Rpl22 deficiency might increase
translation of p53 mRNA indirectly by regulating the ex-
pression of an intermediate(s) that controls p53 synthesis.
We detected no obvious difference in the spectrum of pro-
teins synthesized by Rpl22/ thymocytes (or MEF; data
not shown); however, this does not exclude the possibility
that Rpl22 is involved in regulating expression of a re-
stricted subset of proteins. Rpl22 has been demonstrated
to stimulate IRES-dependent translation, which is acti-
vated in response to a number of types of cellular stress
that activate p53 (Holcik and Sonenberg, 2005; Rubbi
and Milner, 2003; Wood et al., 2001).
Irrespective of the precise mechanism by which p53
synthesis is increased by Rpl22 deficiency, the cell-type
specificity of p53 induction is remarkable in its restriction
to the ab T cell lineage. p53 induction is not observed in
Rpl22/ gd-lineage precursors, despite the fact that the
ab and gd lineages are thought to diverge from a common
precursor just prior to the point of arrest (Ciofani et al.,
2006; Petrie et al., 1992). The differential susceptibility to
Rpl22 deficiency does correlate with differences in
Rpl22 expression. gd and DN3 thymocytes express rela-
tively lower amounts of Rpl22, which are then increased
in ab-lineage cells as they traverse the b-selection check-
point in response to pre-TCR signals. This increase in
Rpl22 expression may be a direct consequence of pre-
TCR signaling on translation of Rpl22 mRNA or on stability
of Rpl22 protein, because its induction is post-transcrip-
tional (data not shown). Alternatively, Rpl22 induction
may be an indirect consequence of the need formore ribo-
some production during the extensive proliferation that
accompanies pre-TCR-induced differentiation beyondthe b-selection checkpoint. There is evidence to suggest
that developing gd-lineage cells undergo far less exten-
sive proliferative expansion than do ab-lineage precursors
(Taghon et al., 2006). Moreover, rapidly dividing cells have
been shown to be more sensitive to p53-mediated apo-
ptosis (Komarova et al., 1997). If proliferation does sensi-
tize Rpl22/ cells to p53-mediated apoptosis, it does so
in a remarkably restricted manner, because Rpl22 defi-
ciency does not affect the countless rounds of prolifera-
tion that occur during embryonic and postnatal develop-
ment of the mouse.
Perhaps most striking is the fact that germline disrup-
tion of the Rpl22 gene is not lethal, as has been reported
for other ribosomal proteins (Matsson et al., 2004). Disrup-
tion of the Rpl22 gene may not be lethal in mice because
Rpl22 is not essential for translation, as previous in vitro
analysis suggests (Lavergne et al., 1987). Because
Rpl22 is well conserved, evidence from model organisms
can also be considered. Disruption of the RPL22A or
RPL22B genes in yeast causes relatively mild growth
defects (Deutschbauer et al., 2005; Giaever et al., 2002).
Reports in Flybase andWormbase indicate that disruption
of the Rpl22 gene in Drosophila and knocking down
expression of Rpl22 by siRNA inC. elegans are both lethal.
However, it should be noted that the Drosophila Rpl22
ortholog has a large, unique N-terminal extension not
found in other species. Moreover, it is possible that the
lethality in worms might result from off-target effects.
Nevertheless, the reason that interfering with Rpl22 func-
tion is lethal during development of invertebrates, but not
during mammalian development, remains unclear at pres-
ent. Efforts to address this issue are ongoing.
In summary, our analysis reveals that Rpl22 plays
a heretofore unsuspected but important role in regulating
development of thymocytes. Indeed, ablation of the Rpl22
gene activates a p53-dependent checkpoint that selec-
tively blocks development of immature precursors of the
ab T lineage. The basis whereby Rpl22 deficiency selec-
tively increases p53 synthesis is currently unclear but
may represent a direct effect on translation of p53
mRNA or an indirect effect mediated by regulating the
expression of intermediates. Efforts to distinguish the
various possibilities should not only clarify the role of
Rpl22 in cellular physiology but should also provide critical
insight into why disrupting Rpl22 function causes such
exquisitely specific developmental abnormalities, despite
its ubiquitous expression.
EXPERIMENTAL PROCEDURES
Generation of Rpl22 Mutant ES Cells and Mice
ES cells harboring a disruption of the Rpl22 gene (Rpl22, accession
number NM_009079) were used to generate Rpl22/ mice bythe indicated Ab. Labeled proteins were visualized by fluorography. P, pulse; 1 hr, 1 hr chase; 2 hr, 2 hr chase. Anti-p53 immunoprecipitation of
labeled p53-expressing (Trp53+/+) and p53-deficient (Trp53/) thymocytes served as a specificity control.
(D) Rpl22 deficiency caused no detectable increase in p53 stability. Phosphorimagery was used to quantify the amount of p53 immunoprecipitated
from the pulse and chase samples above. The proportion of p53 remaining during the chase was expressed as a percentage of that synthesized
during the pulse. The mean ± standard deviation from three experiments was depicted graphically.Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc. 769
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wicz et al., 2003). The precise genomic insertion site of the retroviral
gene-trapping vector in the Rpl22 gene was determined by inverse
genomic PCR on tail DNA as described (Silver and Keerikatte, 1989).
Oligonucleotide primers (LTR2, 50-AAATGGCGTTACTTAAGC
TAGCTTGC-30; A, 50-ACGGTGGGCCTAGAGTTAGTTAGA-30; and B,
50-CACCAAGGACCCGTATTAACCAAC-30 ) were employed in a multi-
plex reaction to genotype mice by performing PCR on tail DNA.
Trp53/ and Rag2/ mice were purchased from Jackson Laborato-
ries (Bar Harbor, ME) and Taconic (Hudson, NY), respectively (Jacks
et al., 1994; Shinkai et al., 1992). Ptcra/ mice were a generous gift
of H. von Boehmer (Harvard University). All mice were maintained at
either the ALAAC-accredited animal facility at Fox Chase Cancer Cen-
ter or at Lexicon Genetics, and all procedures were approved by the
respective institutional animal care and use committees.
Comprehensive Phenotypic Analysis of Rpl22/ Mice
Comprehensive clinical diagnostic and pathologic analysis designed
to identify modulation of therapeutically relevant aspects of mamma-
lian physiology was performed as described in Beltrandelrio et al.
(2003). All experiments were carried out on 10- to 16-week-old mice
representing both sexes.
Complete Blood Cell Counts and Flow Cytometry
Complete blood cell count (CBC) analysis was performed on blood
isolated from the retroorbital sinus with either Cell-Dyn 3500 (Abbott
Diagnostics, Abbott Park, IL) or HemaVet 850 FS (Drew Scientific,
Inc., Oxford, CT) instruments. For flow-cytometry analysis of whole
blood, erythrocytes (RBC) were lysed by hypotonic shock, after which
mononuclear cells were washed once in FACS wash buffer (FWB:
PBS/0.1% BSA/0.1% NaN3/2 mM EDTA), stained for 30 min at 4
C
with fluorochrome-conjugated antibodies (Ab), and washed prior to
analysis. Single-cell suspensions of thymus, spleen, and lymph node
cells were stained as above except that prior to staining, Fc receptors
were blocked for 15 min at 4C with anti-CD16/CD32 (Fc Block, BD
PharMingen, San Diego, CA). Samples were analyzed with either
a FACSCalibur flow cytometer and CellQuest Pro software (Becton
Dickinson Immunocytometry Systems, San Jose, CA) or a FACSVan-
tageSE (BD PharMingen) with FlowJo Software (Treestar, Ashland,
OR). For Annexin V staining, cell suspensions were incubated at
room temperature with PE-Annexin V for 15 min. All Ab were pur-
chased from BD PharMingen unless otherwise specified. Intracellular
TCRb staining was performed as described (Lefebvre et al., 2005).
Bone-Marrow Transplantation
Recipient mice were irradiated with two doses (separated by 3 hr) of
475 rads from a 137Cs source (GAMMATORG-50-B Gamma Irradiator,
JL Shepherd & Associates, San Fernando, CA). Donor BM cells were
flushed from the femurs and tibias of donor mice, and then 1 3 106
donor BM cells were injected into the lateral tail vein of each recipient
mouse within 16–24 hr after irradiation. After transplantation, mice
were housed in SPF facilities and provided with neomycin sulfate
(1.1 g/L) in the drinking water. Reconstitution was monitored by per-
forming FACS on retro-orbital bleeds as well as by performing quanti-
tative PCR for Neo (in the trapping cassette) on peripheral blood
leukocytes.
OP9 Cultures
Fetal livers were harvested at day 14 of gestation and genotyped as
above. Hematopoietic precursors were enriched from single-cell liver
suspensions by banding on a cushion of lympholyte M (CEDARLANE
Laboratories Ltd., Ontario, Canada) for 10 min at 2800 rpm. Isolated
cells were then seeded into 6-well dishes of OP9-DL1 monolayers at
10,000 cells per well in 5 ng/ml each of Flt3L and IL-7 (R&D Systems,
Inc., Minneapolis, MN). Cultures were passaged every 4 days as
described (Schmitt and Zuniga-Pflucker, 2002). On day 4, precursors
were spin-infectedwith virus containing the empty IRES-GFP retroviral
vector, pMiG, or with pMiG containing the coding region of the murine770 Immunity 26, 759–772, June 2007 ª2007 Elsevier Inc.Rpl22 cDNA as described (Lefebvre et al., 2005). For p53 knockdown
experiments, precursors were infected with control vector (LMP) or
LMP-p53shRNA kindly provided by S. Lowe (Cold Spring Harbor Lab-
oratory). After infection, the infected precursors were transferred to
fresh OP9-DL1 monolayers for the indicated culture period before
analysis by flow cytometry as above.
Immunoblot Analysis
Thymocytes and splenocytes were lysed in RIPA buffer (20mMHEPES
[pH 7.0], 150 mM NaCl, 1% deoxycholate, 1% NP-40, 0.1% SDS,
1mMNa2VO4, 2mMEDTA, and a complete protease inhibitor cocktail;
Roche, Basel, Switzerland), resolved by 13% SDS-PAGE, and blotted
with the following Ab as described (Carleton et al., 1999): (1) anti-Rpl22
(Transduction Labs, San Jose, CA); (2) anti-p53 (Novocastra, Newcas-
tle, UK); and (3) anti-calnexin (D. McKean, Mayo Institute) (Schreiber
et al., 1994). MEFswere prepared fromday 14 fetal embryos according
to standard methods. MEF cultures that were 60%–80% confluent
were either mock treated or treated with UV (50J/m2) with a UV Stra-
talinker 1800 (Stratagene). After culture, detergent extracts of the cells
were blotted as above.
Stimulation of Peripheral T Cells and Thymocytes
Enriched T cell preparations from Rpl22+/+ and Rpl22/ mice were
prepared by panning single-cell suspensions of splenocytes for 1 hr
at 37Con petri dishes coated with rabbit anti-mouse immunoglobulin.
T cells were stimulated at 1 3 106/ml in 96-well dishes coated with
10 mg/ml anti-CD3 (145-2C11). After 20 hr, the extent of apoptosis
was measured by Annexin staining as above. Rag2/ thymocytes
were stimulated with anti-CD3 by i.p. injection with 10 mg/g body
weight of anti-CD3 and then harvested at the indicated time.
Pulse-Chase Analysis
Rag2/ thymocytes were harvested 40 hr after i.p. injection of anti-
CD3 as above. Explanted cells were labeled with [35S]methionine at
1 mCi/ml in cysteine- and methionine-free medium for 30 min, then
chased for the indicated time. Aliquots of NP40 detergent extracts
were precipitated onto nitrocellulose filters in 10% TCA to determine
total incorporation of radioactivity. Subsequently, clarified extracts
were immunoprecipitated with anti-p53 (SC-6243, Santa Cruz Bio-
technology, Inc., Santa Cruz, CA) followed by anti-CD33 as described
(Kearse et al., 1994). Isolated proteins were resolved by SDS-PAGE
and visualized by fluorography.
Statistics
Data from Rpl22/ mice were compared with those from Rpl22+/
and Rpl22+/+ by a two-tailed Student’s t test.
Supplemental Data
Six figures are available at http://www.immunity.com/cgi/content/full/
26/6/759/DC1/.
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